Report Detail

Request for Sample of this report

Pharma & Healthcare Global Type 2 Diabetes Medication Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4514019
    • |
  • 19 February, 2023
    • |
  • Global
    • |
  • 111 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

This Report focus on medications for type 2 diabetes.
People with type 2 diabetes are often given medications including insulin to help manage their blood glucose levels. Most of these medications are in the form of tablets, but some are given by injection. Tablets or injections are intended to be used in conjunction with healthy eating and regular physical activity, not as a substitute.
According to our (Global Info Research) latest study, the global Type 2 Diabetes Medication market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Type 2 Diabetes Medication market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Type 2 Diabetes Medication market size and forecasts, in consumption value ($ Million), 2018-2029
Global Type 2 Diabetes Medication market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Type 2 Diabetes Medication market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Type 2 Diabetes Medication market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Type 2 Diabetes Medication
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Type 2 Diabetes Medication market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Novartis, Novo Nordisk, Johnson & Johnson and Boehringer Ingelheim, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Type 2 Diabetes Medication market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Biguanides
Sulphonylureas
Thiazolidinediones
Alpha-glucosidase Inhibitors
DPP-4 Inhibitors
GLP-1 Receptor Agonists
SGLT-2 Inhibitors
Insulins
Market segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by players, this report covers
AstraZeneca
Novartis
Novo Nordisk
Johnson & Johnson
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
Merck
Sanofi
Pfizer
Astellas Pharma
Daiichi Sankyo
Biocon
Glenmark
Bayer AG
Takeda
Sun pharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Type 2 Diabetes Medication product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Type 2 Diabetes Medication, with revenue, gross margin and global market share of Type 2 Diabetes Medication from 2018 to 2023.
Chapter 3, the Type 2 Diabetes Medication competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Type 2 Diabetes Medication market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Type 2 Diabetes Medication.
Chapter 13, to describe Type 2 Diabetes Medication research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Type 2 Diabetes Medication
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Type 2 Diabetes Medication by Type
    • 1.3.1 Overview: Global Type 2 Diabetes Medication Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Type 2 Diabetes Medication Consumption Value Market Share by Type in 2022
    • 1.3.3 Biguanides
    • 1.3.4 Sulphonylureas
    • 1.3.5 Thiazolidinediones
    • 1.3.6 Alpha-glucosidase Inhibitors
    • 1.3.7 DPP-4 Inhibitors
    • 1.3.8 GLP-1 Receptor Agonists
    • 1.3.9 SGLT-2 Inhibitors
    • 1.3.10 Insulins
  • 1.4 Global Type 2 Diabetes Medication Market by Application
    • 1.4.1 Overview: Global Type 2 Diabetes Medication Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital Pharmacies
    • 1.4.3 Retail Pharmacies
    • 1.4.4 Online Pharmacies
  • 1.5 Global Type 2 Diabetes Medication Market Size & Forecast
  • 1.6 Global Type 2 Diabetes Medication Market Size and Forecast by Region
    • 1.6.1 Global Type 2 Diabetes Medication Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Type 2 Diabetes Medication Market Size by Region, (2018-2029)
    • 1.6.3 North America Type 2 Diabetes Medication Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Type 2 Diabetes Medication Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Type 2 Diabetes Medication Market Size and Prospect (2018-2029)
    • 1.6.6 South America Type 2 Diabetes Medication Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Type 2 Diabetes Medication Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 AstraZeneca
    • 2.1.1 AstraZeneca Details
    • 2.1.2 AstraZeneca Major Business
    • 2.1.3 AstraZeneca Type 2 Diabetes Medication Product and Solutions
    • 2.1.4 AstraZeneca Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 AstraZeneca Recent Developments and Future Plans
  • 2.2 Novartis
    • 2.2.1 Novartis Details
    • 2.2.2 Novartis Major Business
    • 2.2.3 Novartis Type 2 Diabetes Medication Product and Solutions
    • 2.2.4 Novartis Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Novartis Recent Developments and Future Plans
  • 2.3 Novo Nordisk
    • 2.3.1 Novo Nordisk Details
    • 2.3.2 Novo Nordisk Major Business
    • 2.3.3 Novo Nordisk Type 2 Diabetes Medication Product and Solutions
    • 2.3.4 Novo Nordisk Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Novo Nordisk Recent Developments and Future Plans
  • 2.4 Johnson & Johnson
    • 2.4.1 Johnson & Johnson Details
    • 2.4.2 Johnson & Johnson Major Business
    • 2.4.3 Johnson & Johnson Type 2 Diabetes Medication Product and Solutions
    • 2.4.4 Johnson & Johnson Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.5 Boehringer Ingelheim
    • 2.5.1 Boehringer Ingelheim Details
    • 2.5.2 Boehringer Ingelheim Major Business
    • 2.5.3 Boehringer Ingelheim Type 2 Diabetes Medication Product and Solutions
    • 2.5.4 Boehringer Ingelheim Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Boehringer Ingelheim Recent Developments and Future Plans
  • 2.6 Bristol-Myers Squibb
    • 2.6.1 Bristol-Myers Squibb Details
    • 2.6.2 Bristol-Myers Squibb Major Business
    • 2.6.3 Bristol-Myers Squibb Type 2 Diabetes Medication Product and Solutions
    • 2.6.4 Bristol-Myers Squibb Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Bristol-Myers Squibb Recent Developments and Future Plans
  • 2.7 Eli Lilly
    • 2.7.1 Eli Lilly Details
    • 2.7.2 Eli Lilly Major Business
    • 2.7.3 Eli Lilly Type 2 Diabetes Medication Product and Solutions
    • 2.7.4 Eli Lilly Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Eli Lilly Recent Developments and Future Plans
  • 2.8 Merck
    • 2.8.1 Merck Details
    • 2.8.2 Merck Major Business
    • 2.8.3 Merck Type 2 Diabetes Medication Product and Solutions
    • 2.8.4 Merck Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Merck Recent Developments and Future Plans
  • 2.9 Sanofi
    • 2.9.1 Sanofi Details
    • 2.9.2 Sanofi Major Business
    • 2.9.3 Sanofi Type 2 Diabetes Medication Product and Solutions
    • 2.9.4 Sanofi Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Sanofi Recent Developments and Future Plans
  • 2.10 Pfizer
    • 2.10.1 Pfizer Details
    • 2.10.2 Pfizer Major Business
    • 2.10.3 Pfizer Type 2 Diabetes Medication Product and Solutions
    • 2.10.4 Pfizer Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Pfizer Recent Developments and Future Plans
  • 2.11 Astellas Pharma
    • 2.11.1 Astellas Pharma Details
    • 2.11.2 Astellas Pharma Major Business
    • 2.11.3 Astellas Pharma Type 2 Diabetes Medication Product and Solutions
    • 2.11.4 Astellas Pharma Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Astellas Pharma Recent Developments and Future Plans
  • 2.12 Daiichi Sankyo
    • 2.12.1 Daiichi Sankyo Details
    • 2.12.2 Daiichi Sankyo Major Business
    • 2.12.3 Daiichi Sankyo Type 2 Diabetes Medication Product and Solutions
    • 2.12.4 Daiichi Sankyo Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Daiichi Sankyo Recent Developments and Future Plans
  • 2.13 Biocon
    • 2.13.1 Biocon Details
    • 2.13.2 Biocon Major Business
    • 2.13.3 Biocon Type 2 Diabetes Medication Product and Solutions
    • 2.13.4 Biocon Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Biocon Recent Developments and Future Plans
  • 2.14 Glenmark
    • 2.14.1 Glenmark Details
    • 2.14.2 Glenmark Major Business
    • 2.14.3 Glenmark Type 2 Diabetes Medication Product and Solutions
    • 2.14.4 Glenmark Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Glenmark Recent Developments and Future Plans
  • 2.15 Bayer AG
    • 2.15.1 Bayer AG Details
    • 2.15.2 Bayer AG Major Business
    • 2.15.3 Bayer AG Type 2 Diabetes Medication Product and Solutions
    • 2.15.4 Bayer AG Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Bayer AG Recent Developments and Future Plans
  • 2.16 Takeda
    • 2.16.1 Takeda Details
    • 2.16.2 Takeda Major Business
    • 2.16.3 Takeda Type 2 Diabetes Medication Product and Solutions
    • 2.16.4 Takeda Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Takeda Recent Developments and Future Plans
  • 2.17 Sun pharma
    • 2.17.1 Sun pharma Details
    • 2.17.2 Sun pharma Major Business
    • 2.17.3 Sun pharma Type 2 Diabetes Medication Product and Solutions
    • 2.17.4 Sun pharma Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 Sun pharma Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Type 2 Diabetes Medication Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Type 2 Diabetes Medication by Company Revenue
    • 3.2.2 Top 3 Type 2 Diabetes Medication Players Market Share in 2022
    • 3.2.3 Top 6 Type 2 Diabetes Medication Players Market Share in 2022
  • 3.3 Type 2 Diabetes Medication Market: Overall Company Footprint Analysis
    • 3.3.1 Type 2 Diabetes Medication Market: Region Footprint
    • 3.3.2 Type 2 Diabetes Medication Market: Company Product Type Footprint
    • 3.3.3 Type 2 Diabetes Medication Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Type 2 Diabetes Medication Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Type 2 Diabetes Medication Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Type 2 Diabetes Medication Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Type 2 Diabetes Medication Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Type 2 Diabetes Medication Consumption Value by Type (2018-2029)
  • 6.2 North America Type 2 Diabetes Medication Consumption Value by Application (2018-2029)
  • 6.3 North America Type 2 Diabetes Medication Market Size by Country
    • 6.3.1 North America Type 2 Diabetes Medication Consumption Value by Country (2018-2029)
    • 6.3.2 United States Type 2 Diabetes Medication Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Type 2 Diabetes Medication Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Type 2 Diabetes Medication Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Type 2 Diabetes Medication Consumption Value by Type (2018-2029)
  • 7.2 Europe Type 2 Diabetes Medication Consumption Value by Application (2018-2029)
  • 7.3 Europe Type 2 Diabetes Medication Market Size by Country
    • 7.3.1 Europe Type 2 Diabetes Medication Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Type 2 Diabetes Medication Market Size and Forecast (2018-2029)
    • 7.3.3 France Type 2 Diabetes Medication Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Type 2 Diabetes Medication Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Type 2 Diabetes Medication Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Type 2 Diabetes Medication Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Type 2 Diabetes Medication Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Type 2 Diabetes Medication Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Type 2 Diabetes Medication Market Size by Region
    • 8.3.1 Asia-Pacific Type 2 Diabetes Medication Consumption Value by Region (2018-2029)
    • 8.3.2 China Type 2 Diabetes Medication Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Type 2 Diabetes Medication Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Type 2 Diabetes Medication Market Size and Forecast (2018-2029)
    • 8.3.5 India Type 2 Diabetes Medication Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Type 2 Diabetes Medication Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Type 2 Diabetes Medication Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Type 2 Diabetes Medication Consumption Value by Type (2018-2029)
  • 9.2 South America Type 2 Diabetes Medication Consumption Value by Application (2018-2029)
  • 9.3 South America Type 2 Diabetes Medication Market Size by Country
    • 9.3.1 South America Type 2 Diabetes Medication Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Type 2 Diabetes Medication Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Type 2 Diabetes Medication Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Type 2 Diabetes Medication Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Type 2 Diabetes Medication Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Type 2 Diabetes Medication Market Size by Country
    • 10.3.1 Middle East & Africa Type 2 Diabetes Medication Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Type 2 Diabetes Medication Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Type 2 Diabetes Medication Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Type 2 Diabetes Medication Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Type 2 Diabetes Medication Market Drivers
  • 11.2 Type 2 Diabetes Medication Market Restraints
  • 11.3 Type 2 Diabetes Medication Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Type 2 Diabetes Medication Industry Chain
  • 12.2 Type 2 Diabetes Medication Upstream Analysis
  • 12.3 Type 2 Diabetes Medication Midstream Analysis
  • 12.4 Type 2 Diabetes Medication Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Type 2 Diabetes Medication. Industry analysis & Market Report on Type 2 Diabetes Medication is a syndicated market report, published as Global Type 2 Diabetes Medication Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Type 2 Diabetes Medication market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo